Atlas Trials

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

Clinical trial NCT01339442 · COMPLETED

Trial details

NCT number
NCT01339442
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Estrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IV Breast Cancer
Start date
2011-11-14
Primary completion
2016-12-21
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.